Chronic myelogenous leukemia: update on biology and treatment.
about
Dual effect of oxidative stress on leukemia cancer induction and treatmentInterleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growthInduction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cellsSemi-supervised prediction of SH2-peptide interactions from imbalanced high-throughput data.Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failureDeterminants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid LeukemiaPHF10 is required for cell proliferation in normal and SV40-immortalized human fibroblast cellsChronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall SurvivalChronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective.Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey.Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Expanding the diversity of allosteric bcr-abl inhibitors.Encapsulation of Piper cabralanum (Piperaceae) nonpolar extract in poly(methyl methacrylate) by miniemulsion and evaluation of increase in the effectiveness of antileukemic activity in K562 cells.Inhibition of Siah2 Ubiquitin Ligase by Vitamin K3 Attenuates Chronic Myeloid Leukemia Chemo-Resistance in Hypoxic Microenvironment.
P2860
Q26866544-AC591EFB-ACC8-449A-9F02-4FD1C8D1D6CBQ33588245-8BCCC660-D579-44ED-964A-DEC1C6D1A3B8Q34273930-69AF0F62-3448-465E-A5B6-CE5EF0ABAF8CQ34729864-C9002A81-6F5E-40C2-B688-285381923E7DQ35596200-017343BB-F197-4BD0-ACEE-D18F485D7048Q36075657-368349C8-B870-4BC0-8753-CC7C30ABBE62Q37011271-CFF81F83-6BF7-4DD4-84CC-FCE6639E3BEFQ37025973-F5D19DE6-851C-4E52-BCCC-44CC7EDDE8DFQ37365606-86255038-5115-4E1C-9B2B-2E80C8A375C7Q37599270-F39CBAB3-021A-4A3A-82B3-818EEB88EC92Q38144200-31E05111-7B85-4F6D-9517-914764FC9EC4Q39657684-4B9E12A8-BABC-47E6-B799-194617B6745FQ47161864-E57FA8D4-D0C5-4041-94C1-504DB86A5934Q49720249-C2B5D5E0-DA75-44F5-A25C-87B03C33ED53
P2860
Chronic myelogenous leukemia: update on biology and treatment.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chronic myelogenous leukemia: update on biology and treatment.
@ast
Chronic myelogenous leukemia: update on biology and treatment.
@en
Chronic myelogenous leukemia: update on biology and treatment.
@nl
type
label
Chronic myelogenous leukemia: update on biology and treatment.
@ast
Chronic myelogenous leukemia: update on biology and treatment.
@en
Chronic myelogenous leukemia: update on biology and treatment.
@nl
prefLabel
Chronic myelogenous leukemia: update on biology and treatment.
@ast
Chronic myelogenous leukemia: update on biology and treatment.
@en
Chronic myelogenous leukemia: update on biology and treatment.
@nl
P1433
P1476
Chronic myelogenous leukemia: update on biology and treatment.
@en
P2093
Moshe Talpaz
P304
169-80; discussion 181, 184
P577
1999-02-01T00:00:00Z